Publications by authors named "Aude Maurousset"

Claim this Profile
P
Presentation and Outcome in S1P-RM and Natalizumab-Associated Progressive Multifocal Leukoencephalopathy: A Multicenter Cohort Study.
Julie C Blant, Nicola N De Rossi, Ralf Gold, Aude Maurousset, Markus Kraemer

Neurol Neuroimmunol Neuroinflamm· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Maintenance Treatment Initiation and Relapse Risk Mitigation After a First Event of MOGAD in Adults: The MOGADOR2 Study.
Romain Deschamps, Jessica Guillaume, Jonathan Ciron, Bertrand Audoin, Aurélie Ruet, Aude Maurousset

Neurology· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 outcomes in patients with multiple sclerosis: Understanding changes from 2020 to 2022.
Lina Jeantin, Edouard Januel, Pierre Labauge, Elisabeth Maillart, Jérôme de Seze, Aude Maurousset

Mult Scler· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association Between Anti-CD20 Therapies and COVID-19 Severity Among Patients With Relapsing-Remitting and Progressive Multiple Sclerosis.
Edouard Januel, David Hajage, Pierre Labauge, Elisabeth Maillart, Jérome De Sèze, Aude Maurousset

JAMA Netw Open· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Profiling Reveals the T-Cell Effect of Ocrelizumab in Early Relapsing-Remitting Multiple Sclerosis.
Alexandra Garcia, Emilie Dugast, Sita Shah, Jérémy Morille, Christine Lebrun-Frenay, Aude Maurousset

Neurol Neuroimmunol Neuroinflamm· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigating the Long-term Effect of Pregnancy on the Course of Multiple Sclerosis Using Causal Inference.
Antoine Gavoille, Fabien Rollot, Romain Casey, Marc Debouverie, Emmanuelle Le Page, Aude Maurousset

Neurology· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving the decision to switch from first- to second-line therapy in multiple sclerosis: A dynamic scoring system.
Camille Sabathé, Romain Casey, Sandra Vukusic, Emmanuelle Leray, Guillaume Mathey, Aude Maurousset

Mult Scler· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kappa Free Light Chain Biomarkers Are Efficient for the Diagnosis of Multiple Sclerosis: A Large Multicenter Cohort Study.
Michael Levraut, Sabine Laurent-Chabalier, Xavier Ayrignac, Kévin Bigaut, Manon Rival, Aude Maurousset

Neurol Neuroimmunol Neuroinflamm· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Effectiveness of Natalizumab Versus Anti-CD20 in Highly Active Relapsing-Remitting Multiple Sclerosis After Fingolimod Withdrawal.
Fabien Rollot, Justine Couturier, Romain Casey, Sandrine Wiertlewski, Marc Debouverie, Aude Maurousset

Neurotherapeutics· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natalizumab Versus Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: A Subgroup Analysis From Three International Cohorts.
Sifat Sharmin, Mathilde Lefort, Johanna Balslev Andersen, Emmanuelle Leray, Dana Horakova, Aude Maurousset

CNS Drugs· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determinants of therapeutic lag in multiple sclerosis.
Izanne Roos, Emmanuelle Leray, Federico Frascoli, Romain Casey, J William L Brown, Aude Maurousset

Mult Scler· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Untreated patients with multiple sclerosis: A study of French expert centers.
Xavier Moisset, Audrey-Anne Fouchard, Bruno Pereira, Frédéric Taithe, Guillaume Mathey, Aude Maurousset

Eur J Neurol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple Sclerosis.
Céline Louapre, Nicolas Collongues, Bruno Stankoff, Claire Giannesini, Caroline Papeix, Aude Maurousset

JAMA Neurol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequency and characteristics of short versus longitudinally extensive myelitis in adults with MOG antibodies: A retrospective multicentric study.
Jonathan Ciron, Alvaro Cobo-Calvo, Bertrand Audoin, Bertrand Bourre, David Brassat, Aude Maurousset

Mult Scler· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perampanel in routine clinical use across Europe: Pooled, multicenter, observational data.
Alexandra Rohracher, Georg Zimmermann, Vicente Villanueva, Iñigo Garamendi, Josemir W Sander, Aude Maurousset

Epilepsia· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term experience with perampanel in refractory epilepsy: Experience at tertiary epilepsy care center in Tours.
Aude Maurousset, Bertrand De Toffol

Epilepsy Behav· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High incidence of obstructive sleep apnea syndrome in patients with late-onset epilepsy.
Aude Maurousset, Bertrand De Toffol, Julien Praline, Julien Biberon, Nadège Limousin

Neurophysiol Clin· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjunctive perampanel in refractory epilepsy: Experience at tertiary epilepsy care center in Tours.
Aude Maurousset, Nadège Limousin, Julien Praline, Julien Biberon, Philippe Corcia

Epilepsy Behav· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis